Faculty profile

Vincent Mooser

ResearcherMcGill University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses may be missing. Find their university profile.

Vincent Mooser

Researcher

Health Sciences

McGill University

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
14 publications in the last five years, latest in 2026.
Senior (last) author on 3 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2018.
Supervised 1 trainee who won CIHR awards, most recently in 2024.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

468

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Cerc

Latest papers

Phenome-Wide Mendelian Randomization Identifying Circulating Proteins for Cardiovascular Traits in Populations of African Ancestry.
Circulation. Genomic and precision medicine · 2026
Frequency enrichment of coding variants in a French-Canadian founder population and its implication for inflammatory bowel diseases.
medRxiv : the preprint server for health sciences · 2025
Integrative proteogenomic analysis identifies COL6A3-derived endotrophin as a mediator of the effect of obesity on coronary artery disease.
Nature genetics · 2025

All 27 publications

Latest funding

Using Large-Scale Genetic Databases to Identify New Therapeutic Targets for Chronic Kidney Disease
CIHR · 2024 · Supervisor
$210,000
The Pan-Canadian Genome Library (PCGL)
CIHR · 2023 · Co-investigator
$14,940,000
Canada Excellence Research Chair In Genemic Medicine: Genes to Drug Targets for Next-Generation Therapies
CIHR · 2018 · Nominated PI
$10,000,000

All 3 grants and awards

27 publications.

Phenome-Wide Mendelian Randomization Identifying Circulating Proteins for Cardiovascular Traits in Populations of African Ancestry.

Selber-Hnatiw S, Trajanoska K, Pelletier J, Su CY, McClelland P, Taliun D, Yoshiji S, Mooser V, Bhérer C, Zhou S

Circulation. Genomic and precision medicine2026

DOI: 10.1161/circgen.125.005159 PMID: 41657222

Frequency enrichment of coding variants in a French-Canadian founder population and its implication for inflammatory bowel diseases.

Bhérer C, Grenier JC, Pelletier J, Boucher G, Gagnon G, Goyette P, Ashton-Beaucage D, Stevens C, Battat R, Bitton A, Campeau PM, Laprise C, NIDDK IBD Genetics Consortium, Quebec IBD Genetics Consortium, iGenoMed Consortium, Huang H, Daly M, Taliun D, Hussin JG, Mooser V, Rioux JD

medRxiv : the preprint server for health sciences2025

DOI: 10.1101/2025.07.11.25331388 PMID: 40791678

Integrative proteogenomic analysis identifies COL6A3-derived endotrophin as a mediator of the effect of obesity on coronary artery disease.

Yoshiji S, Lu T, Butler-Laporte G, Carrasco-Zanini-Sanchez J, Su CY, Chen Y, Liang K, Willett JDS, Wang S, Adra D, Ilboudo Y, Sasako T, Koyama S, Nakao T, Forgetta V, Farjoun Y, Zeberg H, Zhou S, Marks-Hultström M, Machiela MJ, Kaalia R, Dashti H, Claussnitzer M, Flannick J, Wareham NJ, Mooser V, Timpson NJ, Langenberg C, Richards JB

Nature genetics2025

DOI: 10.1038/s41588-024-02052-7 PMID: 39856218

Genetically Enriched Clinical Trials for Precision Development of Noncancer Therapeutics: A Scoping Review.

Delabays B, De Paoli C, Miller-Nesbitt A, Mooser V

Annual review of pharmacology and toxicology2025Senior author

DOI: 10.1146/annurev-pharmtox-031524-021631 PMID: 39348854

Cardiovascular Pharmacogenetics: From Discovery of Genetic Association to Clinical Adoption of Derived Test.

Delabays B, Trajanoska K, Walonoski J, Mooser V

Pharmacological reviews2024Senior author

DOI: 10.1124/pharmrev.123.000750 PMID: 39122647

Development of a long noncoding RNA-based machine learning model to predict COVID-19 in-hospital mortality.

Devaux Y, Zhang L, Lumley AI, Karaduzovic-Hadziabdic K, Mooser V, Rousseau S, Shoaib M, Satagopam V, Adilovic M, Srivastava PK, Emanueli C, Martelli F, Greco S, Badimon L, Padro T, Lustrek M, Scholz M, Rosolowski M, Jordan M, Brandenburger T, Benczik B, Agg B, Ferdinandy P, Vehreschild JJ, Lorenz-Depiereux B, Dörr M, Witzke O, Sanchez G, Kul S, Baker AH, Fagherazzi G, Ollert M, Wereski R, Mills NL, Firat H

Nature communications2024

DOI: 10.1038/s41467-024-47557-1 PMID: 38769334

A cost-effective sequencing method for genetic studies combining high-depth whole exome and low-depth whole genome.

Bhérer C, Eveleigh R, Trajanoska K, St-Cyr J, Paccard A, Nadukkalam Ravindran P, Caron E, Bader Asbah N, McClelland P, Wei C, Baumgartner I, Schindewolf M, Döring Y, Perley D, Lefebvre F, Lepage P, Bourgey M, Bourque G, Ragoussis J, Mooser V, Taliun D

NPJ genomic medicine2024

DOI: 10.1038/s41525-024-00390-3 PMID: 38326393

From target discovery to clinical drug development with human genetics.

Trajanoska K, Bhérer C, Taliun D, Zhou S, Richards JB, Mooser V

Nature2023Senior author

DOI: 10.1038/s41586-023-06388-8 PMID: 37612393

Circulating proteins to predict COVID-19 severity.

Su CY, Zhou S, Gonzalez-Kozlova E, Butler-Laporte G, Brunet-Ratnasingham E, Nakanishi T, Jeon W, Morrison DR, Laurent L, Afilalo J, Afilalo M, Henry D, Chen Y, Carrasco-Zanini J, Farjoun Y, Pietzner M, Kimchi N, Afrasiabi Z, Rezk N, Bouab M, Petitjean L, Guzman C, Xue X, Tselios C, Vulesevic B, Adeleye O, Abdullah T, Almamlouk N, Moussa Y, DeLuca C, Duggan N, Schurr E, Brassard N, Durand M, Del Valle DM, Thompson R, Cedillo MA, Schadt E, Nie K, Simons NW, Mouskas K, Zaki N, Patel M, Xie H, Harris J, Marvin R, Cheng E, Tuballes K, Argueta K, Scott I, Mount Sinai COVID-19 Biobank Team, Greenwood CMT, Paterson C, Hinterberg MA, Langenberg C, Forgetta V, Pineau J, Mooser V, Marron T, Beckmann ND, Kim-Schulze S, Charney AW, Gnjatic S, Kaufmann DE, Merad M, Richards JB

Scientific reports2023

DOI: 10.1038/s41598-023-31850-y PMID: 37069249

Proteome-wide Mendelian randomization implicates nephronectin as an actionable mediator of the effect of obesity on COVID-19 severity.

Yoshiji S, Butler-Laporte G, Lu T, Willett JDS, Su CY, Nakanishi T, Morrison DR, Chen Y, Liang K, Hultström M, Ilboudo Y, Afrasiabi Z, Lan S, Duggan N, DeLuca C, Vaezi M, Tselios C, Xue X, Bouab M, Shi F, Laurent L, Münter HM, Afilalo M, Afilalo J, Mooser V, Timpson NJ, Zeberg H, Zhou S, Forgetta V, Farjoun Y, Richards JB

Nature metabolism2023

DOI: 10.1038/s42255-023-00742-w PMID: 36805566

Something wrong or missing on this profile? Suggest a correction

Vincent Mooser

Research

Latest papers

Latest funding

Phenome-Wide Mendelian Randomization Identifying Circulating Proteins for Cardiovascular Traits in Populations of African Ancestry.

Frequency enrichment of coding variants in a French-Canadian founder population and its implication for inflammatory bowel diseases.

Integrative proteogenomic analysis identifies COL6A3-derived endotrophin as a mediator of the effect of obesity on coronary artery disease.

Genetically Enriched Clinical Trials for Precision Development of Noncancer Therapeutics: A Scoping Review.

Cardiovascular Pharmacogenetics: From Discovery of Genetic Association to Clinical Adoption of Derived Test.

Development of a long noncoding RNA-based machine learning model to predict COVID-19 in-hospital mortality.

A cost-effective sequencing method for genetic studies combining high-depth whole exome and low-depth whole genome.

From target discovery to clinical drug development with human genetics.

Circulating proteins to predict COVID-19 severity.

Proteome-wide Mendelian randomization implicates nephronectin as an actionable mediator of the effect of obesity on COVID-19 severity.

Using Large-Scale Genetic Databases to Identify New Therapeutic Targets for Chronic Kidney Disease

The Pan-Canadian Genome Library (PCGL)

Canada Excellence Research Chair In Genemic Medicine: Genes to Drug Targets for Next-Generation Therapies

Frequent collaborators

Guillaume Butler-Laporte

Sirui Zhou

Daniel Taliun

Marc Afilalo

Jonathan Afilalo

Guillaume Bourque

Satoshi Yoshiji

Simon Rousseau

Mark Lathrop

Erwin Schurr

Daniel Taliun

Yann Joly

Madeleine Durand

Madeleine Durand

Robert Sladek

Jonathan Afilalo

Guillaume Paré

Mark Walker

Mark Walker

Alain Bitton

Anne-Marie Mes-Masson

Michael Pollak

Catherine Larochelle

David Langlais

Gustavo Turecki

Guillaume Lettre

George Thanassoulis

Tomi Pastinen

Nathalie Grandvaux

Catherine Laprise